Seguir
Michel Erlewyn-Lajeunesse
Michel Erlewyn-Lajeunesse
Afiliação desconhecida
Email confirmado em uhs.nhs.uk
Título
Citado por
Citado por
Ano
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data
JU Ruggeberg, MS Gold, JM Bayas, MD Blum, J Bonhoeffer, ...
Vaccine 25 (31), 5675-5684, 2007
4592007
Management of nut allergy influences quality of life and anxiety in children and their mothers
AJ Cummings, RC Knibb, M Erlewyn‐Lajeunesse, RM King, G Roberts, ...
Pediatric Allergy and Immunology 21 (4p1), 586-594, 2010
2122010
How do teenagers manage their food allergies?
H Monks, MH Gowland, H MacKenzie, M Erlewyn‐Lajeunesse, R King, ...
Clinical & Experimental Allergy 40 (10), 1533-1540, 2010
1572010
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
JOB Hourihane, K Beyer, A Abbas, M Fernández-Rivas, PJ Turner, ...
The Lancet Child & Adolescent Health 4 (10), 728-739, 2020
1202020
Randomised controlled trial of combined paracetamol and ibuprofen for fever
MDS Erlewyn-Lajeunesse, K Coppens, LP Hunt, PJ Chinnick, P Davies, ...
Archives of Disease in Childhood 91 (5), 414-416, 2006
1152006
Safety of live attenuated influenza vaccine in atopic children with egg allergy
PJ Turner, J Southern, NJ Andrews, E Miller, M Erlewyn-Lajeunesse, ...
Journal of Allergy and Clinical Immunology 136 (2), 376-381, 2015
1022015
Hyperimmunoglobulin‐E syndrome with recurrent infection: a review of current opinion and treatment
MDS Erlewyn‐Lajeunesse
Pediatric allergy and immunology 11 (3), 133-141, 2000
982000
Recommendations for the administration of influenza vaccine in children allergic to egg
M Erlewyn-Lajeunesse, N Brathwaite, JSA Lucas, JO Warner
Bmj 339, 2009
872009
Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study
PJ Turner, J Southern, NJ Andrews, E Miller, M Erlewyn-Lajeunesse
Bmj 351, 2015
862015
The psychological impact of diagnostic food challenges to confirm the resolution of peanut or tree nut allergy
RC Knibb, NF Ibrahim, G Stiefel, R Petley, AJ Cummings, RM King, ...
Clinical & Experimental Allergy 42 (3), 451-459, 2012
742012
Anaphylaxis as an adverse event following immunisation in the UK and Ireland
M Erlewyn-Lajeunesse, LP Hunt, PT Heath, A Finn
Archives of disease in childhood 97 (6), 487-490, 2012
672012
What factors affect the carriage of epinephrine auto-injectors by teenagers?
C Macadam, J Barnett, G Roberts, G Stiefel, R King, ...
Clinical and translational allergy 2, 1-7, 2012
562012
Bronchoalveolar lavage MMP-9 and TIMP-1 in preschool wheezers and their relationship to persistent wheeze
MDS Erlewyn-Lajeunesse, LP Hunt, P Pohunek, SJ Dobson, P Kochhar, ...
Pediatric research 64 (2), 194-199, 2008
482008
Phase 3 trial of epicutaneous immunotherapy in toddlers with peanut allergy
M Greenhawt, SB Sindher, J Wang, M O’Sullivan, G Du Toit, EH Kim, ...
New England Journal of Medicine 388 (19), 1755-1766, 2023
472023
Validation of the P aediatric F ood A llergy Q uality of L ife Q uestionnaire (PFA‐QL)
RC Knibb, NF Ibrahim, R Petley, AJ Cummings, RM King, G Roberts, ...
Pediatric Allergy and Immunology 24 (3), 288-292, 2013
432013
Severity and threshold of peanut reactivity during hospital‐based open oral food challenges: an international multicenter survey
PD Arkwright, J MacMahon, J Koplin, S Rajput, S Cross, R Fitzsimons, ...
Pediatric Allergy and Immunology 29 (7), 754-761, 2018
412018
Anaphylaxis as an adverse event following immunisation
M Erlewyn-Lajeunesse, J Bonhoeffer, JU Ruggeberg, PT Heath
Journal of clinical pathology 60 (7), 737-739, 2007
302007
In vitro rapid diagnostic tests for severe drug hypersensitivity reactions in children
WY Haw, ME Polak, C McGuire, M Erlewyn-Lajeunesse, ...
Annals of Allergy, Asthma & Immunology 117 (1), 61-66, 2016
282016
Diagnostic utility of two case definitions for anaphylaxis: a comparison using a retrospective case notes analysis in the UK
M Erlewyn-Lajeunesse, S Dymond, I Slade, HL Mansfield, R Fish, ...
Drug safety 33, 57-64, 2010
282010
Brighton Collaboration Anaphylaxis Working Group Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data
JU Rüggeberg, MS Gold, JM Bayas, MD Blum, J Bonhoeffer, ...
Vaccine 25 (31), 5675-5684, 2007
272007
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20